Dabur Pharma, Ghaziabad based company for cancer research and anticancer products, on Monday said that it received the requisite shareholders approval for the change of name of the company to Fresenius Kabi Oncology.
Continued here:
Dabur Pharma receives approval for name change (Business Standard India)
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.